Publications by authors named "Hossein Borghaei"

92Publications

Targeting -Mutant Non-Small-Cell Lung Cancer: One Mutation at a Time, With a Focus on Mutations.

J Clin Oncol 2020 Dec 26;38(35):4208-4218. Epub 2020 Oct 26.

Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne University, Switzerland.

View Article and Find Full Text PDF
December 2020

Biomarker Testing in Lung Cancer-What Does It Mean?

JAMA Netw Open 2020 06 1;3(6):e207171. Epub 2020 Jun 1.

Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

View Article and Find Full Text PDF
June 2020

Combining Immunotherapy and Chemotherapy for Non-Small Cell Lung Cancer.

Thorac Surg Clin 2020 May 2;30(2):199-206. Epub 2020 Mar 2.

Department of Hematology/Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA. Electronic address:

View Article and Find Full Text PDF
May 2020

Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC).

Cancer 2020 01 6;126(2):260-270. Epub 2019 Nov 6.

Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

View Article and Find Full Text PDF
January 2020

Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.

N Engl J Med 2019 11 28;381(21):2020-2031. Epub 2019 Sep 28.

From the Memorial Sloan Kettering Cancer Center, New York (M.D.H.); Hospital Universitario Doce de Octubre, Centro Nacional de Investigaciones Oncológicas, Universidad Complutense, and Centro de Investigación Biomédica en Red de Cáncer, Madrid (L.P.-A.), Hospital Universitario Virgen Del Rocio, Seville (R.B.C.), and the Catalan Institute of Oncology-Germans Trias i Pujol Hospital, Badalona (E.C.C.) - all in Spain; Ambulatorium Chemioterapii, Bydgoszcz, Poland (B.Z.); the Asan Medical Center (S.-W.K.) and the Samsung Medical Center at Sungkyunkwan University School of Medicine (K.P.) - both in Seoul, South Korea; the Institute of Oncology Prof. Dr. Alexandru Trestioreanu, Bucharest, Romania (A.A.); the Hospital Italiano de Buenos Aires, Buenos Aires (L.L.); Instituto Jalisciense de Cancerologia, Guadalajara, Mexico (E.M.J.); the Saitama Cancer Center, Saitama, Japan (H.S.); Matrai Gyogyintezet, Matrahaza, Hungary (I.A.); Limoges University Hospital, Limoges (A.V.), and Aix-Marseille University, National Center for Scientific Research, INSERM, Centre de Recherche en Cancérologie de Marseille, Assistance Publique-Hôpitaux de Marseille, Marseille (F.B.) - all in France; Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland (S.P.); Sotiria General Hospital, National and Kapodistrian University of Athens, Athens (K.S.); Lung Clinic Grosshansdorf, Airway Research Center North, German Center of Lung Research, Grosshansdorf, Germany (M.R.); Fox Chase Cancer Center, Philadelphia (H.B.); Johns Hopkins Kimmel Cancer Center, Baltimore (J.R.B.); Princess Alexandra Hospital, Brisbane, QLD, Australia (K.J.O.); Bristol-Myers Squibb, Princeton, NJ (W.J.G., P.B., S.K.R., R.S.K., F.E.N.); and Winship Cancer Institute, Emory University, Atlanta (S.S.R.).

View Article and Find Full Text PDF
November 2019

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors.

Adv Ther 2019 10 13;36(10):2638-2678. Epub 2019 Aug 13.

Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.

View Article and Find Full Text PDF
October 2019

Nivolumab plus ipilimumab in non-small-cell lung cancer.

Future Oncol 2019 Jul 8;15(19):2287-2302. Epub 2019 May 8.

Princess Alexandra Hospital, Translational Research Institute and Queensland University of Technology, Brisbane, QLD 4102, Australia.

View Article and Find Full Text PDF
July 2019